|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stathis A and Moore MJ: Advanced
pancreatic carcinoma: Current treatment and future challenges. Nat
Rev Clin Oncol. 7:163–172. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vincent A, Herman J, Schulick R, Hruban RH
and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Boeck S, Ankerst DP and Heinemann V: The
role of adjuvant chemotherapy for patients with resected pancreatic
cancer: Systematic review of randomized controlled trials and
meta-analysis. Oncology. 72:314–321. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Normile D: Asian medicine. The new face of
traditional Chinese medicine. Science. 299:188–190. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qi Z, Yin F, Lu L, Shen L, Qi S, Lan L,
Luo L and Yin Z: Baicalein reduces lipopolysaccharide-induced
inflammation via suppressing JAK/STATs activation and ROS
production. Inflamm Res. 62:845–855. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kang KA, Zhang R, Piao MJ, Chae S, Kim HS,
Park JH, Jung KS and Hyun JW: Baicalein inhibits oxidative
stress-induced cellular damage via antioxidant effects. Toxicol Ind
Health. 28:412–421. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen K, Zhang S, Ji Y, Li J, An P, Ren H,
Liang R, Yang J and Li Z: Baicalein inhibits the invasion and
metastatic capabilities of hepatocellular carcinoma cells via
down-regulation of the ERK pathway. PLoS One. 8:e729272013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guo Z, Hu X, Xing Z, Xing R, Lv R, Cheng
X, Su J, Zhou Z, Xu Z, Nilsson S and Liu Z: Baicalein inhibits
prostate cancer cell growth and metastasis via the
caveolin-1/AKT/mTOR pathway. Mol Cell Biochem. 406:111–119. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Marcinkowski EF, Raz D, Shen B, Xing Q,
Yan J, Wen W, et al: Baicalein and meformin decrease small cell
lung cancer growth by inhibiting the mTOR pathway in itro. Cancer
Res. 76:21832016. View Article : Google Scholar
|
|
11
|
Liu Q, Li J, Pu G, Zhang F, Liu H and
Zhang Y: Co-delivery of baicalein and doxorubicin by hyaluronic
acid decorated nanostructured lipid carriers for breast cancer
therapy. Drug Deliv. 23:1364–1368. 2016.PubMed/NCBI
|
|
12
|
Choi EO, Park C, Hwang HJ, Hong SH, Kim
GY, Cho EJ, Kim WJ and Choi YH: Baicalein induces apoptosis via
ROS-dependent activation of caspases in human bladder cancer 5637
cells. Int J Oncol. 49:1009–1018. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Peng Y, Guo C, Yang Y, Li F, Zhang Y,
Jiang B and Li Q: Baicalein induces apoptosis of human cervical
cancer HeLa cells in vitro. Mol Med Rep. 11:2129–2134. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang L, Ling Y, Chen Y, Li CL, Feng F, You
QD, Lu N and Guo QL: Flavonoid baicalein suppresses adhesion,
migration and invasion of MDA-MB-231 human breast cancer cells.
Cancer Lett. 297:42–48. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang F, Dai W, Wang Y, Shen M, Chen K,
Cheng P, Zhang Y, Wang C, Li J, Zheng Y, et al: The synergistic in
vitro and in vivo antitumor effect of combination therapy with
salinomycin and 5-fluorouracil against hepatocellular carcinoma.
PLoS One. 9:e974142014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li-Weber M: New therapeutic aspects of
flavones: The anticancer properties of Scutellaria and its main
active constituents Wogonin, Baicalein and Baicalin. Cancer Treat
Rev. 35:57–68. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu C, Zhang Z, Zhang H, Zhen Z, Calway T,
Wang Y, Yuan CS and Wang CZ: Pretreatment of baicalin and
wogonoside with glycoside hydrolase: A promising approach to
enhance anticancer potential. Oncol Rep. 30:2411–2418. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Takahashi H, Chen MC, Pham H, Angst E,
King JC, Park J, Brovman EY, Ishiguro H, Harris DM, Reber HA, et
al: Baicalein, a component of Scutellaria baicalensis, induces
apoptosis by Mcl-1 down-regulation in human pancreatic cancer
cells. Biochim Biophys Acta. 1813:1465–1474. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ling Y, Chen Y, Chen P, Hui H, Song X, Lu
Z, Li C, Lu N and Guo Q: Baicalein potently suppresses angiogenesis
induced by vascular endothelial growth factor through the p53/Rb
signaling pathway leading to G1/S cell cycle arrest. Exp Biol Med
(Maywood). 236:851–858. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Knudson CM and Korsmeyer SJ: Bcl-2 and Bax
function independently to regulate cell death. Nat Genet.
16:358–363. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Breckenridge DG and Xue D: Regulation of
mitochondrial membrane permeabilization by BCL-2 family proteins
and caspases. Curr Opin Cell Biol. 16:647–652. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mobahat M, Narendran A and Riabowol K:
Survivin as a preferential target for cancer therapy. Int J Mol
Sci. 15:2494–2516. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hassan M, Watari H, AbuAlmaaty A, Ohba Y
and Sakuragi N: Apoptosis and molecular targeting therapy in
cancer. Biomed Res Int. 2014:1508452014. View Article : Google Scholar : PubMed/NCBI
|
